China

China shares biobank with researchers worldwide

By ZHOU WENTING in Shanghai | chinadaily.com.cn

Updated: 2026-11-16 15:53

Share - WeChat
Shanghai Ruijin Hospital announces the latest achievements of the China Metabolic Analytics Project, or ChinaMAP, the most comprehensive genomics database in China to date, on Saturday, and declares it open to the global community. [Photo provided to chinadaily.com.cn]

Shanghai Ruijin Hospital announced the latest achievements of the China Metabolic Analytics Project, the most comprehensive genomics database in China to date, on the World Diabetes Day, which fell on Saturday this year, and declared it open to the global community.

This initiative aims to collaborate with researchers both domestically and internationally to tackle global challenges related to metabolic diseases and tumors and ultimately contribute to human health.

Metabolic diseases include not only diabetes, obesity and cardiovascular diseases, but are also closely linked to tumors and represent a major risk factor accelerating aging, according to medical experts.

Ruijin Hospital, which is affiliated with Shanghai Jiao Tong University School of Medicine, emphasized that such large-scale, evidence-based medical data from the Chinese population is of significant importance for understanding the evolution of metabolic diseases globally and for generating more original research outcomes.

Jointly spearheaded by the National Clinical Research Center for Metabolic Diseases at Ruijin and a number of research institutions and hospitals nationwide, ChinaMAP, the database, is a comprehensive biobank integrating nationwide cohort studies and randomized clinical trials led by Ruijin Hospital and spanning the country.

A cohort study is one in which a group of people are observed over a period of time to form a health analysis. One study involved, for example, is an obesity genetic study involving 10,000 participants under the age of 30 with BMI over 30.

Another example is a clinical trial involving over 12,000 patients across 145 centers nationwide, which found after five years of observation that enhanced systolic blood pressure treatment reduces the risk of major cardiovascular events by more than 20 percent, rewriting international clinical guidelines for hypertension and diabetes.

Wang Weiqing, director of the national center at Ruijin, said that the database aggregates research resources from 5 million people and tens of millions of biological samples. This creates an original data foundation tailored to the Chinese population, overcoming the past reliance on data from European and American populations in related genetic research.

She noted that previously, international basic research, including genetic studies of metabolic diseases and genetic mapping of some endocrine and classic tumor diseases, predominantly used data from Caucasian populations.

"With ChinaMAP, we can provide local evidence for the precise prediction and intervention of metabolic diseases, and also offer important references for related research in East Asian and surrounding populations," said Wang.

Since its public release in November 2024, the biobank has supported 4,400 research projects both domestically and internationally, resulting in a series of scientific achievements. These include a domestic research team using the database to discover a gene linked to the early detection of coronary heart disease, and a South Korean research team building their national biobank based on this model.

Based on ChinaMAP, Ruijin Hospital aims to build an open ecosystem for the global research community, including universities, research institutions, and medical organizations. The official website of the biobank will provide a professional, secure, and efficient collaborative space for global partners, said the hospital.

"Its operational model will also serve as a Chinese paradigm for digital management and international integration of large-scale scientific research projects in the future," Wang said.

The China-SCO Cooperation Center for Metabolic Diseases was launched at Ruijin Hospital in February, aiming to deepen health partnerships among members of the Shanghai Cooperation Organization and enhance the well-being of all people.

Copyright 1994 -

Registration Number: 130349

Mobile